Cargando…
Persistent Risk of Severe Covid-19 in Heart Transplant Recipients: A National Cohort Study
PURPOSE: Vaccination and therapeutic monoclonal antibodies (mAb) provide high protection against severe forms of SARS-CoV-2 infection (COVID-19) in the general population. In France, vaccination campaign started on December 2020 and the first mAb was approved on August 2021. This national cohort stu...
| Autores principales: | , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Published by Elsevier Inc.
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10068033/ http://dx.doi.org/10.1016/j.healun.2023.02.427 |